GlassScriptPhysician profile
Albert Jones Chinn
NPI 1801857305
$7,336.75
in general payments reported to CMS, 2019-2025
35 companies · $1,372 in 2025
The $1,372 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $885 · 2020: $744 · 2021: $996 · 2022: $930 · 2023: $1,433 · 2024: $976 · 2025: $1,372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,606 · Education: $176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,605.71 |
| Education | $175.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,747.06 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,234.43 | 2019-2025 | Fasenra, Tezspire, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $619.37 | 2019-2025 | Ofev |
| Actelion Pharmaceuticals US, INC. | $481.46 | 2019-2025 | Opsumit, Uptravi, Opsynvi |
| Mallinckrodt Hospital Products INC. | $424.72 | 2020-2025 | Acthar |
| Regeneron Healthcare Solutions, INC. | $313.11 | 2019-2025 | Dupixent |
| Mylan Specialty L.P. | $270.79 | 2019-2024 | Yupelri |
| Genzyme Corporation | $260.21 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $209.43 | 2020-2025 | Glassia |
| Insmed, INC. | $200.71 | 2019-2025 | Arikayce, Brinsupri |
| Grifols USA, LLC | $191.16 | 2020-2025 | Prolastin-C Liquid |
| Philips North America LLC | $173.60 | 2019-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Genentech USA, INC. | $107.19 | 2019-2023 | Xolair |
| Vifor Pharma, INC. | $106.77 | 2024-2025 | Zemaira |
| Sanofi-Aventis U.S. LLC | $95.99 | 2025 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $90.04 | 2019-2024 | Nuzyra |
| Sunovion Pharmaceuticals INC. | $82.44 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $81.01 | 2019-2021 | |
| Baxter Healthcare | $80.72 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Monarch Airway Clearance System, Hillrom - Life 2000 Ventilation System |
| Viatris Specialty LLC | $74.59 | 2025 | Yupelri |
| Mallinckrodt Enterprises LLC | $70.27 | 2019 | |
| Electromed, INC. | $58.67 | 2021-2023 | Smartvest |
| Shire North American Group INC | $50.41 | 2019 | |
| Inogen, INC. | $48.13 | 2022-2024 | |
| Ceribell, INC. | $37.77 | 2023 | Ceribell Rapid Response Eeg |
| Ani Pharmaceuticals, INC. | $34.83 | 2022-2023 | Purified Cortrophin Gel |
| Abbvie INC. | $29.55 | 2024 | |
| Circassia INC. | $26.33 | 2019 | |
| United Therapeutics Corporation | $24.26 | 2022 | |
| Novartis Pharmaceuticals Corporation | $23.76 | 2025 | |
| Verona Pharma, INC. | $21.83 | 2025 | Ohtuvayre |
| Bayer Healthcare Pharmaceuticals INC. | $19.39 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $16.44 | 2021 | |
| Monaghan Medical Corporation | $15.75 | 2023 | Aerobika |
| Siemens Medical Solutions USA, INC. | $14.56 | 2025 | Rapidpoint 400/405/500 Wash/Waste Cartridge |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Chinn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.